Optometrists back Aussie-developed AI system

Australian optometrists are reporting positive results with a homegrown clinical decision support tool that uses artificial intelligence (AI) to analyse retinal images for features of the major blinding eye diseases. Read more

Biotech tax cut and trachoma feature in Federal Budget

A tax cut for medical and biotech companies generating income from new patents developed in Australia, a further expansion of a traineeship wage subsidy and $19.1 million towards trachoma elimination are the main 2021-22 Federal Budget announcements affecting the ophthalmic sector. Read more

Fears new buying group could limit patient freedom

The creep of US-style managed care in Australia and reduced competition in the optical market are among major concerns raised with the competition watchdog as it considers the formation of a new buying group to collectively negotiate contracts with healthcare providers.

Read more

Changing the way patients pay

Buy now, pay later is the latest trend in flexible payment services. With financial providers racing to grab their share, what impact is this having for the eyecare sector in terms of new customers, product sales and cash flow? RHIANNON BOWMAN reports.

Read more